SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-033543
Filing Date
2021-03-09
Accepted
2021-03-09 08:30:20
Documents
14
Period of Report
2021-03-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm219108d1_8k.htm   iXBRL 8-K 26166
2 EXHIBIT 99.1 tm219108d1_ex99-1.htm EX-99.1 210594
6 GRAPHIC tm219108d1_ex99-1img001.jpg GRAPHIC 55388
  Complete submission text file 0001104659-21-033543.txt   507566

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA anip-20210309.xsd EX-101.SCH 3217
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE anip-20210309_lab.xml EX-101.LAB 34592
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE anip-20210309_pre.xml EX-101.PRE 22731
7 EXTRACTED XBRL INSTANCE DOCUMENT tm219108d1_8k_htm.xml XML 3467
Mailing Address 210 MAIN STREET WEST BAUDETTE MN 56623
Business Address 210 MAIN STREET WEST BAUDETTE MN 56623 2186343500
ANI PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

IRS No.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31812 | Film No.: 21724163
SIC: 2834 Pharmaceutical Preparations